当前位置:首页 - 行情中心 - 德展健康(000813) - 财务分析 - 现金流量表

德展健康

(000813)

  

流通市值:67.72亿  总市值:67.74亿
流通股本:20.97亿   总股本:20.97亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金128,268,207.1480,060,929.88421,198,891.67339,094,067.94
  收到的税费返还721.99-513,044.82234,309.63
  收到其他与经营活动有关的现金41,827,756.2539,785,923.4154,572,563.4341,326,129.59
  经营活动现金流入小计170,096,685.38119,846,853.29476,284,499.92380,654,507.16
  购买商品、接受劳务支付的现金18,945,977.398,320,540.467,313,202.2435,662,171.34
  支付给职工以及为职工支付的现金118,694,291.0559,296,808.5232,606,269.85162,756,597.55
  支付的各项税费26,026,416.511,159,079.3462,880,229.5641,267,667.46
  支付其他与经营活动有关的现金58,723,894.2224,983,955.56108,762,315.15114,556,921
  经营活动现金流出小计222,390,579.16103,760,383.8471,562,016.8354,243,357.35
  经营活动产生的现金流量净额-52,293,893.7816,086,469.494,722,483.1226,411,149.81
二、投资活动产生的现金流量:
  收回投资收到的现金6,000,0003,000,00010,000,0005,000,000
  取得投资收益收到的现金0-35,101.192,932.82
  处置固定资产、无形资产和其他长期资产收回的现金净额393,175303,665577,987.66366,067.06
  投资活动现金流入小计6,393,1753,303,66510,613,088.855,368,999.88
  购建固定资产、无形资产和其他长期资产支付的现金115,439,130.6480,838,187.75235,988,546.05156,921,325.46
  投资支付的现金300,000,000300,000,000460,000,00040,000,000
  投资活动现金流出小计415,439,130.64380,838,187.75695,988,546.05196,921,325.46
  投资活动产生的现金流量净额-409,045,955.64-377,534,522.75-685,375,457.2-191,552,325.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金004,000,0004,000,000
  其中:子公司吸收少数股东投资收到的现金--4,000,000-
  取得借款收到的现金00114,800,000114,800,000
  筹资活动现金流入小计00118,800,000118,800,000
  偿还债务支付的现金500,000500,0002,368,571.421,868,571.42
  分配股利、利润或偿付利息支付的现金1,124,017.91556,914.581,481,244.51887,527.99
  支付其他与筹资活动有关的现金3,103,493.431,254,380.88135,746,711.96133,250,168.01
  筹资活动现金流出小计4,727,511.342,311,295.46139,596,527.89136,006,267.42
  筹资活动产生的现金流量净额-4,727,511.34-2,311,295.46-20,796,527.89-17,206,267.42
四、汇率变动对现金及现金等价物的影响0070.9370.96
五、现金及现金等价物净增加额-466,067,360.76-363,759,348.72-701,449,431.04-182,347,372.23
  加:期初现金及现金等价物余额1,756,129,111.091,756,129,111.092,457,578,542.132,457,578,542.13
  期末现金及现金等价物余额1,290,061,750.331,392,369,762.371,756,129,111.092,275,231,169.9
补充资料:
  净利润-75,307,710.7--421,925,827.96-
  资产减值准备3,178,189.5-179,756,793.34-
  固定资产和投资性房地产折旧32,724,289.55-63,524,228.41-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧32,724,289.55-63,524,228.41-
  无形资产摊销6,849,139.37-20,521,007.66-
  长期待摊费用摊销9,679,949.47-18,266,939.23-
  处置固定资产、无形资产和其他长期资产的损失8,635.4--1,378,451.21-
  固定资产报废损失412,864.02-85,100.06-
  公允价值变动损失-46,935.06--81,338.21-
  财务费用1,311,539.78-29,998,457.29-
  投资损失1,427,611.6-27,869,182.51-
  递延所得税997,502.29--2,672,867.9-
  其中:递延所得税资产减少1,797,858.05-9,418,990.96-
    递延所得税负债增加-800,355.76--12,091,858.86-
  存货的减少12,473,170.41-42,277,219.26-
  经营性应收项目的减少-27,382,908.68--6,657,452.74-
  经营性应付项目的增加-34,130,760.67--6,201,594.76-
  债务转为资本--0-
  一年内到期的可转换公司债券--0-
  融资租入固定资产--0-
  现金的期末余额1,290,061,750.33-1,756,129,111.09-
  减:现金的期初余额1,756,129,111.09-2,457,578,542.13-
  加:现金等价物的期末余额--0-
  减:现金等价物的期初余额--0-
  现金及现金等价物的净增加额-466,067,360.76--701,449,431.04-
公告日期2026-08-292026-04-252026-04-252025-10-25
审计意见(境内)标准无保留意见
TOP↑